Newswise — Moving patients suspected to have malignant hyperthermia to a hospital is just one of the topics discussed at the May 24th online live presentation for ambulatory surgical center healthcare professionals and administrative staff hosted by MHAUS and presented by Mohanad Shukry, M.D.
Space limited to 95 attendees. More information about the event and registration can be found at this link: http://bit.ly/IVK8DB. $10 for MHAUS members, $20 for non-MHAUS members
Attendees receive follow up email and packet by mail.
Mohanad Shukry, M.D.: Associate Chief, Division of Pediatric Anesthesia at The Children’s Hospital, Oklahoma City, OK; and Program Director, Pediatric Anesthesia Fellowship at University of Oklahoma Health Sciences Center, and Division Chief, Pediatric Cardiac Anesthesia at University of Oklahoma Health Sciences Center.
What is Malignant Hyperthermia
Malignant Hyperthermia (MH) is an inherited muscle disorder triggered by certain types of anesthesia that may cause a fast-acting life-threatening crisis. The incidence of MH is low, but, if untreated, the mortality rate is high. Great advances in the understanding of MH have been made since it was first recognized in the early 1960s, but the nature of the fundamental defect(s) is still unknown. More information at MHAUS.org
Founding in 1981 MHAUS promotes optimum care and scientific understanding of MH and related disorders by encouraging medical professionals and patients and families to prepare for MH through education and testing, and providing life-saving services such as the MH 24-hour Hotline.